Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00552084 · ClinicalTrials.gov registry record · Phase 4

Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation

A Phase 4 study of Atrial Fibrillation, sponsored by Vanderbilt University.

Completed
Registry status
Phase 4
Development phase
190
Enrollment target
1
Study location

NCT00552084 is a Phase 4 study of Atrial Fibrillation that has completed, run by Vanderbilt University. The registered enrollment target is 190 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00552084, a Phase 4 study of Atrial Fibrillation, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
Phase 4
Development phase
190 participants
Enrollment target
1
Study location

Study Summary

Atrial fibrillation (AF) is a heart rhythm disorder that usually involves a rapid heart rate. People who take fish oil supplements may reduce the risk of a recurrence of AF. This study will evaluate the effectiveness of fish oil at decreasing the recurrence of AF and will examine the reasons why fish oil may reduce this risk.

Conditions Studied

Atrial Fibrillation

Interventions

  • DRUG Placebo
  • DRUG Fish oil

Study Locations (1)

Tennessee

  • Vanderbilt Medical School - Nashville

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2007-11
Est. Completion 2014-04
Phase Phase 4

Sponsor

Vanderbilt University

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00552084

The ClinicalTrials.gov registry entry for NCT00552084 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (94% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00552084 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00552084 about?

NCT00552084 is a clinical study titled "Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation". Atrial fibrillation (AF) is a heart rhythm disorder that usually involves a rapid heart rate. People who take fish oil supplements may reduce the risk of a recurrence of AF. This study will evaluate the effectiveness of fish oil at decreasing the recurrence of AF and will examine the reasons why fis...

What is the current status of trial NCT00552084?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 190 participants. The study started on 2007-11. Estimated completion is 2014-04.

What conditions does trial NCT00552084 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT00552084?

The interventions under investigation include: Placebo (DRUG), Fish oil (DRUG).

Who is sponsoring clinical trial NCT00552084?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00552084 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.